Literature DB >> 25600157

Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume.

Tom J van Mierlo1, Chin Chung, Elisabeth M Foncke, Henk W Berendse, Odile A van den Heuvel.   

Abstract

Depression and anxiety are common in Parkinson's disease (PD), and are among the non-motor symptoms that interfere with quality of life dramatically. Motor, cognitive, and affective features overlap in PD, hampering diagnosis. To shed more light on the contribution of structural brain changes to the presence of PD-related depressive symptoms, we conducted a Voxel-Based Morphometry (VBM) study. We hypothesized that depressive symptoms in PD are related to regional gray matter (GM) volume loss within the limbic circuit. We analyzed the T1-weigthed magnetic resonance imaging (MRI) images of 67 PD patients with a mean disease duration of 2.95 (±3.39) years. Scores on the Beck Depression Inventory (BDI) and GM probability maps were analyzed by regression analysis to study the association between GM volume and severity of depressive symptoms. Results are reported at both the uncorrected and the family-wise error (FWE) corrected level for multiple comparisons. The BDI scores correlated negatively with bilateral hippocampus and right amygdala volume and positively with the volume of the anterior cingulate cortex. These findings confirm the hypothesized involvement of the limbic circuit in PD-related depressive symptoms. We speculate that non-dopaminergic changes are essential in the pathophysiology of depressive symptoms in PD, because our findings suggest the involvement of extra-striatal brain regions.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; amygdala; anxiety; depression; hippocampus; structural MRI; voxel-based morphometry

Mesh:

Year:  2015        PMID: 25600157     DOI: 10.1002/mds.26112

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  33 in total

1.  Cortical thinning in drug-naive Parkinson's disease patients with depression.

Authors:  ChunYan Luo; Wei Song; Qin Chen; Jing Yang; QiYong Gong; Hui-Fang Shang
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

2.  Affective Correlates of Psychosis in Parkinson's Disease.

Authors:  Stewart A Factor; Michael K Scullin; Alan Freeman; Donald L Bliwise; William M McDonald; Felicia C Goldstein
Journal:  Mov Disord Clin Pract       Date:  2016-06-16

3.  Impaired long contact white matter fibers integrity is related to depression in Parkinson's disease.

Authors:  Jia-Yong Wu; Yang Zhang; Wen-Bo Wu; Gang Hu; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-11-10       Impact factor: 5.243

Review 4.  Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.

Authors:  Stephane Thobois; Stephane Prange; Véronique Sgambato-Faure; Léon Tremblay; Emmanuel Broussolle
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-18       Impact factor: 5.081

5.  Heterotopic 4T1 breast cancer transplantation induces hippocampal inflammation and depressive-like behaviors in mice.

Authors:  Wenjing Yan; Hulin Zhu; Pengbo Zhang; Ting Sun; Shuai Gong; Guoxiu Sun; Zeqiang Ren
Journal:  Metab Brain Dis       Date:  2022-08-10       Impact factor: 3.655

6.  Neuronal Nitric Oxide Synthase-Mediated Genotoxicity of 2-Methoxyestradiol in Hippocampal HT22 Cell Line.

Authors:  Magdalena Gorska; Michal A Zmijewski; Alicja Kuban-Jankowska; Maciej Wnuk; Iwona Rzeszutek; Michal Wozniak
Journal:  Mol Neurobiol       Date:  2015-09-17       Impact factor: 5.590

7.  N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.

Authors:  Rosalia Crupi; Daniela Impellizzeri; Marika Cordaro; Rosalba Siracusa; Giovanna Casili; Maurizio Evangelista; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-03-19       Impact factor: 5.590

Review 8.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

9.  Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.

Authors:  Zacharias Kohl; Nada Ben Abdallah; Jonathan Vogelgsang; Lucas Tischer; Janina Deusser; Davide Amato; Scott Anderson; Christian P Müller; Olaf Riess; Eliezer Masliah; Silke Nuber; Jürgen Winkler
Journal:  Neurobiol Dis       Date:  2015-10-30       Impact factor: 5.996

10.  Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease.

Authors:  Sule Tinaz; Serageldin Kamel; Sai S Aravala; Mine Sezgin; Mohamed Elfil; Rajita Sinha
Journal:  J Neurol Sci       Date:  2021-02-21       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.